Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.67 |
| ▸ | HSP90AA1 | P07900 | 9/20 | 0.56 |
| ▸ | XDH | P47989 | 1/20 | 0.44 |
| ▸ | TYR | P14679 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Agnuside SCHEMBL24174405 | 1.00 | L3MBTL1 (0.67) | L3MBTL1HSP90AA1XDHTYRCA12 | |
| Agnuside SCHEMBL13208121 | 1.00 | L3MBTL1 (0.67) | L3MBTL1HSP90AA1XDHTYRCA12 | |
| SCHEMBL7153129 | 0.93 | L3MBTL1 (0.67) | L3MBTL1HSP90AA1XDHCA12CA1 | |
| Eurostoside SCHEMBL29425819 | 0.85 | L3MBTL1 (0.62) | L3MBTL1HSP90AA1XDHCA12CA1 | |
| SCHEMBL29425816 | 0.83 | L3MBTL1 (0.63) | L3MBTL1HSP90AA1XDHTYR | |
| Aucubin SCHEMBL381032 | 0.81 | L3MBTL1 (1.00) | L3MBTL1HSP90AA1XDH | |
| Aucubin SCHEMBL22680275 | 0.81 | L3MBTL1 (1.00) | L3MBTL1HSP90AA1XDH | |
| Aucubin SCHEMBL22680274 | 0.81 | L3MBTL1 (1.00) | L3MBTL1HSP90AA1XDH | |
| SCHEMBL13998199 | 0.78 | KMT2A (0.42) | L3MBTL1HSP90AA1CA12CA1CA2 | |
| SCHEMBL382085 | 0.77 | STAT3 (0.44) | L3MBTL1HSP90AA1TYRCA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114878704-A | Fingerprint spectrum construction method of fructus viticis and multi-index content detection method | 广东一方制药有限公司 | 2022-08-09 | — | — | CN | claimed |
| US-20210230206-A1 | METHOD FOR SEPARATING NATURAL SUBSTANCE MIXTURES BY MEANS OF SCPC | Spectrum Therapeutics GmbH (DE) | 2021-07-29 | — | — | US | claimed |
| EP-3630326-A1 | METHOD FOR SEPARATING NATURAL SUBSTANCE MIXTURES BY MEANS OF SCPC | Bionorica Ethics GmbH (DE) | 2020-04-08 | — | — | EP | claimed |
| US-7780997-B2 | Pharmaceutically active extracts of vitex leucoxylon, a process of extracting the same and a method of treating diabetes and inflammatory diseases therewith | LAILA IMPEX (IN) | 2010-08-24 | — | — | US | claimed |
| EP-2120922-A2 | COMPOSITIONS COMPRISING LAMIRIDOSIN, IRIDOIDS OR DERIVATIVES THEREOF FOR TREATMENT OF HEPATITIS C OR HEPATITIS B | NY Financial (International) Corporation (VG) | 2009-11-25 | — | — | EP | claimed |
| CN-100512811-C | Hepatoprotective activity of 10-O-p-hydroxybenzoyl aucubin | COUNCIL SCIENT IND RES (IN) | 2009-07-15 | — | — | CN | claimed |
| US-20080319042-A1 | Compositions and methods for treatment of liver disease | CALECO PHARMA CORP. | 2008-12-25 | — | — | US | claimed |
| US-20080199543-A1 | Pharmaceutically Active Extracts of Vitex Leucoxylon, a Process of Extracting the Same and a Method of Treating Diabetes and Inflammatory Diseases Therewith | LAILA IMPEX (IN) | 2008-08-21 | — | — | US | claimed |
| WO-2008100547-A2 | COMPOSITIONS COMPRISING LAMIRIDOSIN, IRIDOIDS OR DERIVATIVES THEREOF FOR TREATMENT OF HEPATITIS C OR HEPATITIS B | NY FINANCIAL (INTERNATIONAL) CORPORATION (VG) | 2008-08-21 | — | — | WO | claimed |
| EP-1509223-B1 | HEPATOPROTECTIVE ACTIVITY OF 10-O-P-HYDROXYBENZOYIAUCUBIN | COUNCIL SCIENT IND RES (IN) | 2008-08-20 | — | — | EP | claimed |
| WO-2007029263-A1 | PHARMACEUTICALLY ACTIVE EXTRACTS OF VITEX LEUCOXYLON, A PROCESS OF EXTRACTING THE SAME AND A METHOD OF TREATING DIABETES AND INFLAMMATORY DISEASES THEREWITH | GOKARAJU GANGA RAJU (IN) | 2007-03-15 | — | — | WO | claimed |
| CN-1658865-A | Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin | COUNCIL SCIENT IND RES (IN) | 2005-08-24 | — | — | CN | claimed |
| EP-1509223-A1 | HEPATOPROTECTIVE ACTIVITY OF 10-O-P-HYDROXYBENZOYIAUCUBIN | Council Of Scientific And Industrial Research (IN) | 2005-03-02 | — | — | EP | claimed |
| EP-1503773-A1 | HEPATOPROTECTIVE ACTIVITY OF 2 -P-HYDROXYBENZOYLMUSSAENOSIDIC ACID | Council of Scientific and Industrial Research (IN) | 2005-02-09 | — | — | EP | claimed |
| US-20040029816-A1 | Hepatoprotective activity of 10-O-P-hydroxybenzoyiaucubin | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH | 2004-02-12 | — | — | US | claimed |
| US-20040014684-A1 | Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2004-01-22 | — | — | US | claimed |
| WO-2003094946-A1 | HEPATOPROTECTIVE ACTIVITY OF 2'-P-HYDROXYBENZOYLMUSSAENOSIDIC ACID | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-11-20 | — | — | WO | claimed |
| WO-2003094911-A1 | HEPATOPROTECTIVE ACTIVITY OF 10-O-P-HYDROXYBENZOYIAUCUBIN | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-11-20 | — | — | WO | claimed |
| US-6242012-B1 | Herbal composition for promoting hormonal balance in women and methods of using same | NEW CHAPTER, INC. | 2001-06-05 | — | — | US | claimed |
| EP-4702037-A1 | METHOD OF PRODUCING IRIDOIDS | Nicoventures Trading Limited (GB) | 2026-03-04 | — | — | EP | disclosed |
| US-12558392-B1 | Herbal oral compositions having the properties for supporting and enhancing musculoskeletal health and method of manufacturing the same | Tran, Dang Huy (VN) | 2026-02-24 | — | — | US | disclosed |
| US-12507703-B2 | Methods, devices and compositions for preserving human milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-12-30 | — | — | US | disclosed |
| US-20250169516-A1 | METHODS, DEVICES AND COMPOSITIONS FOR PRESERVING HUMAN MILK | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-05-29 | — | — | US | disclosed |
| US-12239142-B2 | Methods, devices and compositions for preserving human milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-03-04 | — | — | US | disclosed |
| US-20250025524-A1 | HERBAL COMPOSITION AND METHOD FOR TREATING OR PREVENTING ACUTE OR CHRONIC PAIN | ENOVATE BIOLIFE PVT. LTD. (IN) | 2025-01-23 | — | — | US | disclosed |
| US-12176074-B2 | Compound function prediction method based on neural network and connectivity map algorithm | BEIJING GIGACEUTICALS TECH. CO. LTD (CN) | 2024-12-24 | — | — | US | disclosed |
| EP-3630326-B1 | METHOD OF SEPARATING NATURAL MIXTURES USING SCPC | CANDORO ETHICS GMBH (DE) | 2024-11-20 | — | — | EP | disclosed |
| WO-2024224085-A1 | METHOD OF PRODUCING IRIDOIDS | Nicoventures Trading Limited (GB) | 2024-10-31 | — | — | WO | disclosed |
| CN-118530943-A | Culture medium for inducing stem cells to transform into nerve cells | 山东宝欣医学科技有限公司 | 2024-08-23 | — | — | CN | disclosed |
| US-20240268402-A1 | Methods, Devices and Compositions for Preserving Human Milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2024-08-15 | — | — | US | disclosed |
| US-20240233878-A9 | COMPOUND FUNCTION PREDICTION METHOD BASED ON NEURAL NETWORK AND CONNECTIVITY MAP ALGORITHM | BEIJING GIGACEUTICALS TECH. CO. LTD (CN) | 2024-07-11 | — | — | US | disclosed |
| US-20240216459-A1 | COMPOSITION FOR PREVENTING AND/OR AMELIORATING MENSTRUAL CYCLE SYMPTOMS AND/OR DISCOMFORTS, AND METHODS OF PRODUCING AND USING THE SAME | ACCESS BUSINESS GROUP INTERNATIONAL LLC | 2024-07-04 | — | — | US | disclosed |
| WO-2024145374-A1 | COMPOSITION FOR PREVENTING AND/OR AMELIORATING MENSTRUAL CYCLE SYMPTOMS AND/OR DISCOMFORTS, AND METHODS OF PRODUCING AND USING THE SAME | ACCESS BUSINESS GROUP INTERNATIONAL LLC (US) | 2024-07-04 | — | — | WO | disclosed |
| US-20240136025-A1 | COMPOUND FUNCTION PREDICTION METHOD BASED ON NEURAL NETWORK AND CONNECTIVITY MAP ALGORITHM | BEIJING GIGACEUTICALS TECH. CO. LTD (CN) | 2024-04-25 | — | — | US | disclosed |
| CN-113178234-B | Compound function prediction method based on neural network and connection graph algorithm | 北京亿药科技有限公司 | 2023-10-31 | — | — | CN | disclosed |
| CN-115025100-B | Application of active ingredient in preparation of medicine for treating diabetic nephropathy | 苏州市中医医院 | 2023-09-05 | — | — | CN | disclosed |
| EP-4164590-A1 | THERAPEUTIC HERBAL COMPOSITIONS FOR IMPROVING JOINT HEALTH | Karallief, Inc. (US) | 2023-04-19 | — | — | EP | disclosed |
| US-11547122-B2 | Preventing physical instability of heat treated dairy based products | ARLA FOODS AMBA (DK) | 2023-01-10 | — | — | US | disclosed |
| CN-115524423-A | Method for constructing and detecting characteristic spectrum of fructus viticis negundo and identifying fructus viticis | 广东一方制药有限公司 | 2022-12-27 | — | — | CN | disclosed |
| US-20220401435-A1 | MRGPRX2 ANTAGONIST FOR THE TREATMENT OF PSEUDO ALLERGIC REACTIONS | THE UNIVERSITY OF HONG KONG | 2022-12-22 | — | — | US | disclosed |
| CN-115025100-A | Application of effective components in preparing medicine for treating diabetic nephropathy | 苏州市中医医院 | 2022-09-09 | — | — | CN | disclosed |
| CN-114994197-A | Method for determining content of components in fructus viticis formula granules by adopting one-test-multiple evaluation method | 山东宏济堂制药集团股份有限公司 | 2022-09-02 | — | — | CN | disclosed |
| WO-2022178961-A1 | COMPOUND FUNCTION PREDICTION METHOD BASED ON NEURAL NETWORK AND CONNECTIVITY MAP ALGORITHM | 北京亿药科技有限公司 | 2022-09-01 | — | — | WO | disclosed |
| CN-114878704-A | Fingerprint spectrum construction method of fructus viticis and multi-index content detection method | 广东一方制药有限公司 | 2022-08-09 | — | — | CN | disclosed |
| WO-2022146272-A1 | STIMULATOR DEVICE FOR PROSOPAGNOSIA PATIENTS THAT WORKS WITH ARTIFICIAL INTELLIGENCE AIDED SENSORY SUBSTITUTION | CUKUROVA UNIVERSITESI REKTORLUGU (TR) | 2022-07-07 | — | — | WO | disclosed |
| EP-4000626-A1 | PHARMACEUTICAL PREPARATION | concrete flowers GmbH (AT) | 2022-05-25 | — | — | EP | disclosed |
| US-11306116-B2 | Method for separating natural substance mixtures by means of SCPC | Spectrum Therapeutics GmbH (DE) | 2022-04-19 | — | — | US | disclosed |
| US-20210230206-A1 | METHOD FOR SEPARATING NATURAL SUBSTANCE MIXTURES BY MEANS OF SCPC | Spectrum Therapeutics GmbH (DE) | 2021-07-29 | — | — | US | disclosed |
| CN-113178234-A | Compound function prediction method based on neural network and connection graph algorithm | 北京亿药科技有限公司 | 2021-07-27 | — | — | CN | disclosed |
| EP-3672428-B1 | PREVENTING PHYSICAL INSTABILITY OF HEAT TREATED DAIRY BASED PRODUCTS | ARLA FOODS AMBA (DK) | 2021-07-07 | — | — | EP | disclosed |
| EP-3836948-A1 | TAMPON | Jäger, Verena (DE) | 2021-06-23 | — | — | EP | disclosed |
| US-20200352185-A1 | PREVENTING PHYSICAL INSTABILITY OF HEAT TREATED DAIRY BASED PRODUCTS | ARLA FOODS AMBA (DK) | 2020-11-12 | — | — | US | disclosed |
| CN-111372476-A | Prevention of physical instability of heat-treated dairy products | 阿尔拉食品公司 | 2020-07-03 | — | — | CN | disclosed |
| EP-3672428-A1 | PREVENTING PHYSICAL INSTABILITY OF HEAT TREATED DAIRY BASED PRODUCTS | Arla Foods Amba (DK) | 2020-07-01 | — | — | EP | disclosed |
| EP-3630326-A1 | METHOD FOR SEPARATING NATURAL SUBSTANCE MIXTURES BY MEANS OF SCPC | Bionorica Ethics GmbH (DE) | 2020-04-08 | — | — | EP | disclosed |
| WO-2020035115-A1 | TAMPON | JAEGER VERENA (DE) | 2020-02-20 | — | — | WO | disclosed |
| CN-110305082-A | The method that rotundifuran is extracted using fructus viticis | 成都格利普生物科技有限公司 | 2019-10-08 | — | — | CN | disclosed |
| WO-2019038392-A1 | PREVENTING PHYSICAL INSTABILITY OF HEAT TREATED DAIRY BASED PRODUCTS | ARLA FOODS AMBA (DK) | 2019-02-28 | — | — | WO | disclosed |
| CN-107897227-A | Method for preventing and treating leaf curl insect pests of Bufosna | 桂林斯泰硕农农业科技有限公司 | 2018-04-13 | — | — | CN | disclosed |
| US-9345660-B2 | Micro-emulsions for the treatment of rheumatic disorders | SUNEV PHARMA SOLUTION LIMITED (IN) | 2016-05-24 | — | — | US | disclosed |
| US-20150086655-A1 | Morinda Citrifolia Juice Formulations Comprising Iridoids | WEST BRETT JUSTIN (US) | 2015-03-26 | — | — | US | disclosed |
| US-8790727-B2 | Morinda citrifolia and iridoid based formulations | TAHITIAN NONI INTERNATIONAL, INC. (US) | 2014-07-29 | — | — | US | disclosed |
| US-8679550-B2 | Morinda citrifolia juice formulations comprising iridoids | TAHITIAN NONI INTERNATIONAL, INC. (US) | 2014-03-25 | — | — | US | disclosed |
| US-20120328720-A1 | Iridoid Based Formulations | MORINDA, INC. | 2012-12-27 | — | — | US | disclosed |
| US-20120093888-A1 | MICRO-EMULSIONS FOR THE TREATMENT OF RHEUMATIC DISORDERS | SUNEV PHARMA SOLUTION LIMITED (IN) | 2012-04-19 | — | — | US | disclosed |
| EP-2437725-A1 | TOPICAL MICRO-EMULSIONS FOR THE TREATMENT OF RHEUMATIC DISORDERS | Sunev Pharma Solution Limited (IN) | 2012-04-11 | — | — | EP | disclosed |
| US-20120021079-A1 | Garcinia Mangostana L. and Iridoid Based Formulations | TAHITIAN NONI INTERNATIONAL, INC. | 2012-01-26 | — | — | US | disclosed |
| EP-1503773-B9 | HEPATOPROTECTIVE ACTIVITY OF 2 -P-HYDROXYBENZOYLMUSSAENOSIDIC ACID | COUNCIL SCIENT IND RES (IN) | 2012-01-25 | — | — | EP | disclosed |
| US-20110217394-A1 | Iridoid Based Formulations | WEST BRETT JUSTIN | 2011-09-08 | — | — | US | disclosed |
| WO-2011106423-A2 | ACAI AND IRIDOID BASED FORMULATIONS | TAHITIAN NONI INTERNATIONAL, INC. (US) | 2011-09-01 | — | — | WO | disclosed |
| WO-2011106417-A2 | GARCINIA MANGOSTANA L. AND IRIDOID BASED FORMULATIONS | TAHITIAN NONI INTERNATIONAL, INC. (US) | 2011-09-01 | — | — | WO | disclosed |
| WO-2011106432-A2 | MORINDA CITRIFOLIA AND IRIDOID BASED FORMULATIONS | TAHITIAN NONI INTERNATIONAL, INC. (US) | 2011-09-01 | — | — | WO | disclosed |
| WO-2011106448-A2 | IRIDOID BASED FORMULATIONS | TAHITIAN NONI INTERNATIONAL, INC. (US) | 2011-09-01 | — | — | WO | disclosed |
| US-20110206786-A1 | Acai and Iridoid Based Formulations | TAHITIAN NONI INTERNATIONAL, INC. | 2011-08-25 | — | — | US | disclosed |
| US-20110206787-A1 | Morinda Citrifolia and Iridoid Based Formulations | MORINDA, INC. | 2011-08-25 | — | — | US | disclosed |
| EP-1503773-B1 | HEPATOPROTECTIVE ACTIVITY OF 2 -P-HYDROXYBENZOYLMUSSAENOSIDIC ACID | COUNCIL SCIENT IND RES (IN) | 2011-03-30 | — | — | EP | disclosed |
| CN-101411718-B | Composition with antiinflammatory and bacteriostatic functions | BEIJING HONGTAI KANGDA PHARMACEUTICAL TECHNOLOGY CO LTD | 2010-12-22 | — | — | CN | disclosed |
| WO-2010140170-A1 | TOPICAL MICRO-EMULSIONS FOR THE TREATMENT OF RHEUMATIC DISORDERS | SUNEV PHARMA SOLUTION LIMITED (IN) | 2010-12-09 | — | — | WO | disclosed |
| CN-101361786-B | Total-flavone extraction and purification and its monomer separation method from Lespedaza bedysaroides | GRASSLAND RES INST CAAS | 2010-10-27 | — | — | CN | disclosed |
| US-7780997-B2 | Pharmaceutically active extracts of vitex leucoxylon, a process of extracting the same and a method of treating diabetes and inflammatory diseases therewith | LAILA IMPEX (IN) | 2010-08-24 | — | — | US | disclosed |
| US-20100143398-A1 | Synergistic Phytoceutical Compositions | OLALDE RANGEL JOSE ANGEL | 2010-06-10 | — | — | US | disclosed |
| US-20100143397-A1 | Synergistic Phytoceutical Compositions | OLALDE RANGEL JOSE ANGEL | 2010-06-10 | — | — | US | disclosed |
| US-7682616-B2 | Synergistic phytoceutical compositions | OLALDE RANGEL JOSE ANGEL | 2010-03-23 | — | — | US | disclosed |
| US-7682617-B2 | Synergistic phytoceutical compositions | OLALDE RANGEL JOSE ANGEL | 2010-03-23 | — | — | US | disclosed |
| EP-1496920-B1 | PHARMACEUTICAL COMPOSITION CONTAINING AN EXTRACT FROM BARLERIA PRIONITIS LINN AND ITS PROCESS OF PREPARATION | COUNCIL SCIENT IND RES (IN) | 2010-03-03 | — | — | EP | disclosed |
| EP-2120922-A2 | COMPOSITIONS COMPRISING LAMIRIDOSIN, IRIDOIDS OR DERIVATIVES THEREOF FOR TREATMENT OF HEPATITIS C OR HEPATITIS B | NY Financial (International) Corporation (VG) | 2009-11-25 | — | — | EP | disclosed |
| US-7618639-B2 | Synergistic phytoceutical compositions | OLALDE RANGEL JOSE ANGEL | 2009-11-17 | — | — | US | disclosed |
| US-7604823-B2 | Synergistic HIV/AIDS and/or immune disease phyto-nutraceutical composition | Olalde Rangel, Jose Angel (US) | 2009-10-20 | — | — | US | disclosed |
| US-20090196941-A1 | Synergistic Phytoceutical Compositions | OLALDE RANGEL JOSE ANGEL | 2009-08-06 | — | — | US | disclosed |
| CN-101486745-A | Induced extracting method for pigeon pea leaf extract rich in flavone activity component | UNIV NORTHEAST FORESTRY (CN) | 2009-07-22 | — | — | CN | disclosed |
| CN-100512811-C | Hepatoprotective activity of 10-O-p-hydroxybenzoyl aucubin | COUNCIL SCIENT IND RES (IN) | 2009-07-15 | — | — | CN | disclosed |
| CN-100512811-C | Hepatoprotective activity of 10-O-p-hydroxybenzoyl aucubin | COUNCIL SCIENT IND RES (IN) | 2009-07-15 | — | — | CN | disclosed |
| US-7553501-B2 | Immune phyto-neutraceutical composition | Olalde Rangel, Jose Angel (US) | 2009-06-30 | — | — | US | disclosed |
| US-20090155377-A1 | Synergistic Phytoceutical Compositions | OLALDE RANGEL JOSE ANGEL | 2009-06-18 | — | — | US | disclosed |
| CN-101411718-A | Composition with antiinflammatory and bacteriostatic functions | BEIJING HONGTAI KANGDA PHARMAC (CN) | 2009-04-22 | — | — | CN | disclosed |
| CN-101361786-A | Total-flavone extraction and purification and its monomer separation method from Lespedaza bedysaroides | INST OF GRASSLAND CHINESE ACAD (CN) | 2009-02-11 | — | — | CN | disclosed |
| US-20080319042-A1 | Compositions and methods for treatment of liver disease | CALECO PHARMA CORP. | 2008-12-25 | — | — | US | disclosed |
| US-20080260771-A1 | PROSTATE DISORDER(S) PHYTO-NUTRACEUTICAL SYNERGISTIC COMPOSITION | OLALDE RANGEL JOSE A | 2008-10-23 | — | — | US | disclosed |
| US-20080199543-A1 | Pharmaceutically Active Extracts of Vitex Leucoxylon, a Process of Extracting the Same and a Method of Treating Diabetes and Inflammatory Diseases Therewith | LAILA IMPEX (IN) | 2008-08-21 | — | — | US | disclosed |
| WO-2008100547-A2 | COMPOSITIONS COMPRISING LAMIRIDOSIN, IRIDOIDS OR DERIVATIVES THEREOF FOR TREATMENT OF HEPATITIS C OR HEPATITIS B | NY FINANCIAL (INTERNATIONAL) CORPORATION (VG) | 2008-08-21 | — | — | WO | disclosed |
| EP-1509223-B1 | HEPATOPROTECTIVE ACTIVITY OF 10-O-P-HYDROXYBENZOYIAUCUBIN | COUNCIL SCIENT IND RES (IN) | 2008-08-20 | — | — | EP | disclosed |
| EP-1509223-B1 | HEPATOPROTECTIVE ACTIVITY OF 10-O-P-HYDROXYBENZOYIAUCUBIN | COUNCIL SCIENT IND RES (IN) | 2008-08-20 | — | — | EP | disclosed |
| US-20080160083-A1 | Delivering effective amounts of Chasteberry Extract, Pyridoxine, and Magnesium in a single dosage unit and a method of treating PMS and related disorders; oral dosage | NORTHERN HOLDINGS INC. | 2008-07-03 | — | — | US | disclosed |
| CN-100391465-C | Hepatoprotective activity of 2' -p-hydroxybenzoylmussaenosidic acid | COUNCIL SCIENT IND RES (IN) | 2008-06-04 | — | — | CN | disclosed |
| US-20080118582-A1 | Synergistic Inmune Phyto-Nutraceutical Composition | OLALDE RANGEL JOSE ANGEL | 2008-05-22 | — | — | US | disclosed |
| US-20080089946-A1 | Synergistic Phytoceutical Compositions | OLALDE RANGEL JOSE A | 2008-04-17 | — | — | US | disclosed |
| US-20080063658-A1 | SYNERGISTIC HIV/AIDS AND/OR IMMUNE DISEASE PHYTO-NUTRACEUTICAL COMPOSITION | OLALDE RANGEL JOSE ANGEL | 2008-03-13 | — | — | US | disclosed |
| CN-100374125-C | Pharmaceutical compsn. contg. extract from barleria prionitis linn and its process of prepn | COUNCIL SCIENT IND RES (IN) | 2008-03-12 | — | — | CN | disclosed |
| US-7303772-B2 | Synergistic phytoceutical compositions | OLALDE RANGEL JOSE ANGEL | 2007-12-04 | — | — | US | disclosed |
| US-7259148-B2 | Hepatoprotective activity of 2′-p-hydroxybenzoylmussaenosidic acid | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2007-08-21 | — | — | US | disclosed |
| WO-2007060368-A1 | PHYTOHORMONAL COMPOSITION AND USE THEREOF AS HORMONAL SUBSTITUTE | PHYSCIENCE (FR) | 2007-05-31 | — | — | WO | disclosed |
| WO-2007059441-A2 | SYNERGISTIC PHYTOCEUTICAL COMPOSITIONS | OLALDE RANGEL JOSE ANGEL (US) | 2007-05-24 | — | — | WO | disclosed |
| US-20070104728-A1 | Synergistic phytoceutical compositions | OLALDE RANGEL JOSE A | 2007-05-10 | — | — | US | disclosed |
| WO-2007029263-A1 | PHARMACEUTICALLY ACTIVE EXTRACTS OF VITEX LEUCOXYLON, A PROCESS OF EXTRACTING THE SAME AND A METHOD OF TREATING DIABETES AND INFLAMMATORY DISEASES THEREWITH | GOKARAJU GANGA RAJU (IN) | 2007-03-15 | — | — | WO | disclosed |
| CN-1658865-A | Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin | COUNCIL SCIENT IND RES (IN) | 2005-08-24 | — | — | CN | disclosed |
| CN-1658865-A | Hepatoprotective activity of 10-o-p-hydroxybenzoyiaucubin | COUNCIL SCIENT IND RES (IN) | 2005-08-24 | — | — | CN | disclosed |
| CN-1652808-A | Hepatoprotective activity of 2' -p-hydroxybenzoylmussaenosidic acid | COUNCIL SCIENT IND RES (IN) | 2005-08-10 | — | — | CN | disclosed |
| CN-1627954-A | Pharmaceutical compsn. contg. extract from barleria prionitis linn and its process of prepn | COUNCIL SCIENT IND RES (IN) | 2005-06-15 | — | — | CN | disclosed |
| EP-1509223-A1 | HEPATOPROTECTIVE ACTIVITY OF 10-O-P-HYDROXYBENZOYIAUCUBIN | Council Of Scientific And Industrial Research (IN) | 2005-03-02 | — | — | EP | disclosed |
| EP-1509223-A1 | HEPATOPROTECTIVE ACTIVITY OF 10-O-P-HYDROXYBENZOYIAUCUBIN | Council Of Scientific And Industrial Research (IN) | 2005-03-02 | — | — | EP | disclosed |
| EP-1503773-A1 | HEPATOPROTECTIVE ACTIVITY OF 2 -P-HYDROXYBENZOYLMUSSAENOSIDIC ACID | Council of Scientific and Industrial Research (IN) | 2005-02-09 | — | — | EP | disclosed |
| EP-1496920-A1 | PHARMACEUTICAL COMPOSITION CONTAINING AN EXTRACT FROM BARLERIA PRIONITIS LINN AND ITS PROCESS OF PREPARATION | Council of Scientific and Industrial Research;an Indian Reg. body incorporated under Reg. of Societies Act (Act XXI of 1860) (IN) | 2005-01-19 | — | — | EP | disclosed |
| CN-1172664-C | Prolactin lowering medicine | �װ�ŵ�￨�ɷݹ�˾ | 2004-10-27 | — | — | CN | disclosed |
| US-20040138297-A1 | Agent for lowering prolactin | WUTTKE WOLFGANG (DE) | 2004-07-15 | — | — | US | disclosed |
| US-20040029816-A1 | Hepatoprotective activity of 10-O-P-hydroxybenzoyiaucubin | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH | 2004-02-12 | — | — | US | disclosed |
| US-20040029816-A1 | Hepatoprotective activity of 10-O-P-hydroxybenzoyiaucubin | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH | 2004-02-12 | — | — | US | disclosed |
| US-20040014684-A1 | Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2004-01-22 | — | — | US | disclosed |
| WO-2003094911-B1 | HEPATOPROTECTIVE ACTIVITY OF 10-O-P-HYDROXYBENZOYIAUCUBIN | COUNCIL SCIENT IND RES (IN) | 2003-12-31 | — | — | WO | disclosed |
| US-6664236-B2 | Mixtures of glucosides obtained by solvent extraction from plants, comprising barlerin, acetyl barlerin, shanshizide methyl esters and adjuvants, used for detoxification, immunomodulation and as anxiolytic agents | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-12-16 | — | — | US | disclosed |
| WO-2003094946-A1 | HEPATOPROTECTIVE ACTIVITY OF 2'-P-HYDROXYBENZOYLMUSSAENOSIDIC ACID | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-11-20 | — | — | WO | disclosed |
| WO-2003094911-A1 | HEPATOPROTECTIVE ACTIVITY OF 10-O-P-HYDROXYBENZOYIAUCUBIN | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-11-20 | — | — | WO | disclosed |
| WO-2003094911-A1 | HEPATOPROTECTIVE ACTIVITY OF 10-O-P-HYDROXYBENZOYIAUCUBIN | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-11-20 | — | — | WO | disclosed |
| US-6635672-B1 | Labdane or celerodane type bicyclic diterpenes; menstrual cycle disorders | BIONORICA AG (DE) | 2003-10-21 | — | — | US | disclosed |
| WO-2003080087-A1 | PHARMACEUTICAL COMPOSITION CONTAINING AN EXTRACT FROM BARLERIA PRIONITIS LINN AND ITS PROCESS OF PREPARATION | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2003-10-02 | — | — | WO | disclosed |
| US-20030181397-A1 | SYNERGISTIC COMPOSITION OF BIOACTIVE FRACTION ISOLATED BARLERIA PRIONITIS LINN AND A METHOD OF TREATMENT FOR HEPATOTOXICITY, IMMUNO-DEFICIENCY AND FATIGUE AND A PROCESS THEREOF | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH | 2003-09-25 | — | — | US | disclosed |
| US-6541045-B1 | Herbal composition and method for combating inflammation | NUTRACEUTICAL CORPORATION | 2003-04-01 | — | — | US | disclosed |
| US-6346267-B1 | ADMINISTERING ESTROGENS AND PHYTOESTROGENS IN FOODS OR HERBS | WAKUNAGA OF AMERICA CO., LTD. | 2002-02-12 | — | — | US | disclosed |
| CN-1326343-A | Prolactin lowering medicine | BRONORICA ARZNEIMITTEL GMBH (DE) | 2001-12-12 | — | — | CN | disclosed |
| US-6242012-B1 | Herbal composition for promoting hormonal balance in women and methods of using same | NEW CHAPTER, INC. | 2001-06-05 | — | — | US | disclosed |
| CN-1239547-A | pharmaceutical grade botanical drug | PHARMAPRINT INC (US) | 1999-12-22 | — | — | CN | disclosed |
| WO-1999021006-A9 | PHARMACEUTICAL GRADE VALERIAN, BLACK COHOSH, VITEX AGNUS-CASTUS, BILBERRY AND MILK THISTLE | PHARMAPRINT INC (US) | 1999-07-08 | — | — | WO | disclosed |
| WO-1999021006-A1 | PHARMACEUTICAL GRADE VALERIAN, BLACK COHOSH, VITEX AGNUS-CASTUS, BILBERRY AND MILK THISTLE | PHARMAPRINT, INC. (US) | 1999-04-29 | — | — | WO | disclosed |
| EP-0900375-A1 | PHARMACEUTICAL GRADE BOTANICAL DRUGS | Pharmaprint, Inc. (US) | 1999-03-10 | — | — | EP | disclosed |
| WO-1997039355-A1 | PHARMACEUTICAL GRADE BOTANICAL DRUGS | PHARMAPRINT, INC. (US) | 1997-10-23 | — | — | WO | disclosed |
| WO-1996010408-A1 | CARDIOACTIVE COMPOUNDS ISOLATED FROM WOODY PERENNIALS | THE EXECUTIVE DIRECTOR OF THE WESTERN AUSTRALIAN DEPARTMENT OF CONSERVATION AND LAND MANAGEMENT (AU) | 1996-04-11 | — | — | WO | disclosed |
| WO-1996010408-A1 | CARDIOACTIVE COMPOUNDS ISOLATED FROM WOODY PERENNIALS | THE EXECUTIVE DIRECTOR OF THE WESTERN AUSTRALIAN DEPARTMENT OF CONSERVATION AND LAND MANAGEMENT (AU) | 1996-04-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080160083-A1 | Delivering effective amounts of Chasteberry Extract, Pyridoxine, and Magnesium in a single dosage unit and a method of treating PMS and related disorders; oral dosage | PNPO, PRDX5, PGR | L3MBTL1 4486/4885HSP90AA1 4411/4885XDH 397/4885 |
| US-12558392-B1 | Herbal oral compositions having the properties for supporting and enhancing musculoskeletal health and method of manufacturing the same | COL2A1, COL1A1, ALPI | L3MBTL1 3981/4885HSP90AA1 263/4885XDH 2736/4885 |
| US-12507703-B2 | Methods, devices and compositions for preserving human milk | LPL, CEL, LPO | L3MBTL1 760/4885HSP90AA1 3411/4885XDH 171/4885 |
| US-20220401435-A1 | MRGPRX2 ANTAGONIST FOR THE TREATMENT OF PSEUDO ALLERGIC REACTIONS | MRGPRX2, MRGPRX1, MRGPRX4 | L3MBTL1 4016/4885HSP90AA1 4548/4885XDH 802/4885 |
| US-20040138297-A1 | Agent for lowering prolactin | PRLHR, ADCYAP1R1, GHRHR | L3MBTL1 708/4885HSP90AA1 3907/4885XDH 2223/4885 |
| US-20080319042-A1 | Compositions and methods for treatment of liver disease | HCCS, HAVCR2, PYGL | L3MBTL1 3689/4885HSP90AA1 3606/4885XDH 17/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.